These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7609088)

  • 1. Suppression of simian immunodeficiency virus replication by human immunodeficiency virus type 1 trans-dominant negative rev mutants.
    Endres CL; Bergquam EP; Axthelm MK; Wong SW
    J Virol; 1995 Aug; 69(8):5164-6. PubMed ID: 7609088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of trans-dominant inhibitory mutant human immunodeficiency virus type 1 genes expressed by retroviral vectors in human T lymphocytes.
    Bahner I; Zhou C; Yu XJ; Hao QL; Guatelli JC; Kohn DB
    J Virol; 1993 Jun; 67(6):3199-207. PubMed ID: 8388497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of mutations in rev gene of SIVmac on virus replication.
    Aavik E; Hakkarainen K; Krohn KJ
    AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S123-8. PubMed ID: 7865286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Rev-inducible mutant gag gene stably transferred into T lymphocytes: an approach to gene therapy against human immunodeficiency virus type 1 infection.
    Smythe JA; Sun D; Thomson M; Markham PD; Reitz MS; Gallo RC; Lisziewicz J
    Proc Natl Acad Sci U S A; 1994 Apr; 91(9):3657-61. PubMed ID: 8170964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of HIV/SIV replication by dominant negative Gag mutants.
    Shimano R; Inubushi R; Oshima Y; Adachi A
    Virus Genes; 1999; 18(3):197-201. PubMed ID: 10456787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complementation of the rev gene mutation among human and simian lentiviruses.
    Sakai H; Shibata R; Miura T; Hayami M; Ogawa K; Kiyomasu T; Ishimoto A; Adachi A
    J Virol; 1990 May; 64(5):2202-7. PubMed ID: 2182909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutational analysis of simian immunodeficiency virus from African green monkeys and human immunodeficiency virus type 2.
    Shibata R; Adachi A; Sakai H; Ishimoto A; Miura T; Hayami M
    J Med Primatol; 1990; 19(3-4):217-25. PubMed ID: 2231682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simian Immunodeficiency Virus (SIV)-Specific Chimeric Antigen Receptor-T Cells Engineered to Target B Cell Follicles and Suppress SIV Replication.
    Haran KP; Hajduczki A; Pampusch MS; Mwakalundwa G; Vargas-Inchaustegui DA; Rakasz EG; Connick E; Berger EA; Skinner PJ
    Front Immunol; 2018; 9():492. PubMed ID: 29616024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of trans-dominant mutants of the HIV type 1 Rev protein for their ability to inhibit Rev function, HIV type 1 replication, and their use as anti-HIV gene therapeutics.
    Ragheb JA; Bressler P; Daucher M; Chiang L; Chuah MK; VandenDriessche T; Morgan RA
    AIDS Res Hum Retroviruses; 1995 Nov; 11(11):1343-53. PubMed ID: 8573391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of human immunodeficiency virus type 1 replication in human T cells by retroviral-mediated gene transfer of a dominant-negative Rev trans-activator.
    Bevec D; Dobrovnik M; Hauber J; Böhnlein E
    Proc Natl Acad Sci U S A; 1992 Oct; 89(20):9870-4. PubMed ID: 1409715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rev/RRE-independent Mason-Pfizer monkey virus constitutive transport element-dependent propagation of SIVmac239 vectors using a single round of replication assay.
    Rizvi TA; Schmidt RD; Lew KA; Keeling ME
    Virology; 1996 Aug; 222(2):457-63. PubMed ID: 8806531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic complementation between replication-defective mutants of HIV-1 and SIVagm.
    Miura T; Shibata R; Adachi A; Kuwata T; Chen J; Jin M; Ido E; Hayami M
    Arch Virol; 1996; 141(1):31-41. PubMed ID: 8629949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The development and testing of retroviral vectors expressing trans-dominant mutants of HIV-1 proteins to confer anti-HIV-1 resistance.
    Liem SE; Ramezani A; Li X; Joshi S
    Hum Gene Ther; 1993 Oct; 4(5):625-34. PubMed ID: 8280800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by HIV-1-based lentivirus vectors expressing transdominant Rev.
    Mautino MR; Keiser N; Morgan RA
    J Virol; 2001 Apr; 75(8):3590-9. PubMed ID: 11264348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An env gene derived from a primary human immunodeficiency virus type 1 isolate confers high in vivo replicative capacity to a chimeric simian/human immunodeficiency virus in rhesus monkeys.
    Reimann KA; Li JT; Voss G; Lekutis C; Tenner-Racz K; Racz P; Lin W; Montefiori DC; Lee-Parritz DE; Lu Y; Collman RG; Sodroski J; Letvin NL
    J Virol; 1996 May; 70(5):3198-206. PubMed ID: 8627800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Requirement of an additional Sam68 domain for inhibition of human immunodeficiency virus type 1 replication by Sam68 dominant negative mutants lacking the nuclear localization signal.
    Zhang J; Liu Y; Henao J; Rugeles MT; Li J; Chen T; He JJ
    Gene; 2005 Dec; 363():67-76. PubMed ID: 16236470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of trans-dominant HIV-1 rev protein mutants by direct transfer of bacterially produced proteins into human cells.
    Mermer B; Felber BK; Campbell M; Pavlakis GN
    Nucleic Acids Res; 1990 Apr; 18(8):2037-44. PubMed ID: 2186373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction of human immunodeficiency virus 1/simian immunodeficiency virus strain mac chimeric viruses having vpr and/or nef of different parental origins and their in vitro and in vivo replication.
    Kuwata T; Igarashi T; Ido E; Jin M; Mizuno A; Chen J; Hayami M
    J Gen Virol; 1995 Sep; 76 ( Pt 9)():2181-91. PubMed ID: 7561755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of a human immunodeficiency virus type 1 Rev mutant without nucleolar dysfunction as a candidate for potential AIDS therapy.
    Furuta RA; Kubota S; Maki M; Miyazaki Y; Hattori T; Hatanaka M
    J Virol; 1995 Mar; 69(3):1591-9. PubMed ID: 7853493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infectious simian/human immunodeficiency virus with human immunodeficiency virus type 1 subtype C from an African isolate: rhesus macaque model.
    Ndung'u T; Lu Y; Renjifo B; Touzjian N; Kushner N; Pena-Cruz V; Novitsky VA; Lee TH; Essex M
    J Virol; 2001 Dec; 75(23):11417-25. PubMed ID: 11689623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.